| Target and Pathway |
Top |
| Target(s) |
Angiotensin II receptor type-2 (AGTR2) |
Target Info
|
Agonist |
[1] |
| Peroxisome proliferator-activated receptor gamma (PPAR-gamma) |
Target Info
|
Agonist |
[1] |
| Target's Patent Info |
Angiotensin II receptor type-2 (AGTR2) |
Target's Patent Info
|
[1] |
| Peroxisome proliferator-activated receptor gamma (PPAR-gamma) |
Target's Patent Info
|
[1] |
|
KEGG Pathway
|
Neuroactive ligand-receptor interaction
|
|
Adrenergic signaling in cardiomyocytes
|
|
Renin-angiotensin system
|
|
PPAR signaling pathway
|
|
AMPK signaling pathway
|
|
Osteoclast differentiation
|
|
Huntington's disease
|
|
Pathways in cancer
|
|
Transcriptional misregulation in cancer
|
|
Thyroid cancer
|
|
NetPath Pathway
|
IL1 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
Leptin Signaling Pathway
|
|
Panther Pathway
|
CCKR signaling map ST
|
|
Pathway Interaction Database
|
Noncanonical Wnt signaling pathway
|
|
Calcineurin-regulated NFAT-dependent transcription in lymphocytes
|
|
Signaling events mediated by HDAC Class I
|
|
RXR and RAR heterodimerization with other nuclear receptor
|
|
Regulation of retinoblastoma protein
|
|
Reactome
|
Peptide ligand-binding receptors
|
|
G alpha (i) signalling events
|
|
PPARA activates gene expression
|
|
Transcriptional regulation of white adipocyte differentiation
|
|
Nuclear Receptor transcription pathway
|
|
WikiPathways
|
ACE Inhibitor Pathway
|
|
GPCRs, Class A Rhodopsin-like
|
|
Peptide GPCRs
|
|
GPCR ligand binding
|
|
GPCR downstream signaling
|
|
Wnt Signaling Pathway Netpath
|
|
Nuclear Receptors in Lipid Metabolism and Toxicity
|
|
Differentiation of white and brown adipocyte
|
|
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
Transcriptional Regulation of White Adipocyte Differentiation
|
|
Adipogenesis
|
|
SREBP signalling
|
|
Nuclear Receptors
|
